rpt
Niamh Russell presented the OPTi-PREDICT teams poster titled ‘Refining Treatment Recommendations for Lymph Node-Negative Breast Cancer Patients using a Novel Protein-Based Prognostic Signature: The OnocMasTR Assay’ at IACR. This was a very well attended session with over 150 posters presented. The poster describes the ongoing antibody validation work, where two markers show useful prognostic ability, validated in an independent cohort. It also describes new work using fluorescent staining, which will allow quantification of protein expression of several markers in the same tissue sample. The team was delighted to be listed in the short-list of posters.
